Sign in

CIK 0001625297

  • Large accelerated filer

Supernus, Inc.

Sign in to watch
Ticker
SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412520873
Phone
+1 804-379-1090
Business address
9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Former names
Indivior Pharmaceuticals, Inc., INDIVIOR PLC
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 8-K Event Regulation FD disclosure
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 8-K Event Results of operations · Regulation FD disclosure
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 8-K Event Material agreement · Regulation FD disclosure
  7. 4 Planned sale Chief Scientific Officer sold 18,586 shares at $41.14 ($764,628)
  8. 144 Insider Sale of Securities
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 612,549 shares (to pay taxes)
  10. 4 Planned sale Chief Scientific Officer sold 18,586 shares at $38.06 ($707,383)
  11. 144 Insider Sale of Securities
  12. 4 Planned sale Chief Financial Officer sold 36,000 shares at $37.70 ($1,357,200)
  13. 144/A Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 8-K Event Executive or director change · Shareholder vote results
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 4 Shares withheld for taxes Director gave up 1,117 shares (to pay taxes)
  18. 4 Grant or award Director acquired 6,518 shares (grant or award)
  19. 4 Grant or award Director acquired 6,518 shares (grant or award)
  20. 4 Grant or award Director acquired 6,518 shares (grant or award)

Page 3 of 29 · 572 filings